Citations (205)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Sneham Tiwari, Venkata Atluri, Ajeet Kaushik, Adriana Yndart & Madhavan Nair. (2019) Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics. International Journal of Nanomedicine 14, pages 5541-5554.
Read now
Read now
Kouichi Shiraishi & Masayuki Yokoyama. (2019) Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review. Science and Technology of Advanced Materials 20:1, pages 324-336.
Read now
Read now
Eun Ji Park, Jiyoung Choi, Kang Choon Lee & Dong Hee Na. (2019) Emerging PEGylated non-biologic drugs. Expert Opinion on Emerging Drugs 24:2, pages 107-119.
Read now
Read now
Massimo Morfini & Carlo Antonio Paolo Rapisarda. (2019) Safety of recombinant coagulation factors in treating hemophilia. Expert Opinion on Drug Safety 18:2, pages 75-85.
Read now
Read now
Zhe Li, LiNa Wang, Xiao Lin, Lan Shen & Yi Feng. (2017) Drug delivery for bioactive polysaccharides to improve their drug-like properties and curative efficacy. Drug Delivery 24:2, pages 70-80.
Read now
Read now
Eun Ji Park, Sung Mook Lim, Kang Choon Lee & Dong Hee Na. (2016) Exendins and exendin analogs for diabetic therapy: a patent review (2012-2015). Expert Opinion on Therapeutic Patents 26:7, pages 833-842.
Read now
Read now
ChunXia Yao, XiaoLi Shi, Xiao Lin, Lan Shen, DeSheng Xu & Yi Feng. (2015) Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats. International Journal of Nanomedicine 10, pages 409-418.
Read now
Read now
XiaoLi Shi, Xiao Lin, XiangWei Zheng, Yi Feng & Lan Shen. (2014) Injectable long-acting systems for Radix Ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot. International Journal of Nanomedicine 9, pages 5555-5563.
Read now
Read now
Sylvère Störmann & Jochen Schopohl. (2014) Emerging drugs for acromegaly. Expert Opinion on Emerging Drugs 19:1, pages 79-97.
Read now
Read now
Pascal Richette & Ricardo Garay. (2013) Novel drug discovery strategies for gout. Expert Opinion on Drug Discovery 8:2, pages 183-189.
Read now
Read now
Russell Becker, Carole Dembek, Leigh Ann White & Louis P Garrison. (2012) The cost offsets and cost–effectiveness associated with pegylated drugs: a review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 775-793.
Read now
Read now
Ricardo P Garay, Raafat El-Gewely, Jonathan K Armstrong, George Garratty & Pascal Richette. (2012) Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. Expert Opinion on Drug Delivery 9:11, pages 1319-1323.
Read now
Read now
Maharajan Sivasubramanian, Yu-Jeong Kim, Su Young Chae, Sohee Son, Dong-Gyu Jo, Kang Choon Lee, Chang Kyoo Yoo & Jae Hyung Park. (2012) Thiolated Glycol Chitosan Bearing α-Cyclodextrin for Sustained Delivery of PEGylated Human Growth Hormone. Journal of Biomaterials Science, Polymer Edition 23:15, pages 1995-2005.
Read now
Read now
Xiao Lin, Zhuo-Jun Wang, Fang Huang, Shuang Liang, Lan Shen, Yi Feng & Ke-Feng Ruan. (2011) Long-circulating delivery of bioactive polysaccharide from radix ophiopogonis by PEGylation. International Journal of Nanomedicine 6, pages 2865-2872.
Read now
Read now
Robert W. Payne, Brian M. Murphy & Mark Cornell Manning. (2011) Product development issues for PEGylated proteins. Pharmaceutical Development and Technology 16:5, pages 423-440.
Read now
Read now
Charlotte Pinholt, Rune Andersen Hartvig, Natalie J Medlicott & Lene Jorgensen. (2011) The importance of interfaces in protein drug delivery – why is protein adsorption of interest in pharmaceutical formulations?. Expert Opinion on Drug Delivery 8:7, pages 949-964.
Read now
Read now
Guilan Sun, Xiao Lin, Zhuojun Wang, Yi Feng, Desheng Xu & Lan Shen. (2011) PEGylated Inulin as Long-Circulating Pharmaceutical Carrier. Journal of Biomaterials Science, Polymer Edition 22:4-6, pages 429-441.
Read now
Read now
Ignazio Olivieri, Salvatore D'Angelo, Carlo Palazzi, Ennio Lubrano & Pietro Leccese. (2010) Emerging drugs for psoriatic arthritis. Expert Opinion on Emerging Drugs 15:3, pages 399-414.
Read now
Read now
Articles from other publishers (187)
Gunnvald Kvarstein, Anna MS Kindlundh‐Högberg, Mounir Ould Setti, Rafik Namane, Ruvimbo Muzwidzwa, Hartmut Richter & Katja M. Hakkarainen. (2023)
An observational post‐authorization safety study (
PASS
) of naloxegol drug utilization in four European countries
. Pharmacoepidemiology and Drug Safety.
Crossref
Crossref
Yongsheng Gao, Maithili Joshi, Zongmin Zhao & Samir Mitragotri. (2023)
PEGylated
therapeutics in the clinic
. Bioengineering & Translational Medicine.
Crossref
Crossref
Shiwen Song, Dong Sun, Hong Wang, Jinliang Wang, Huijing Yan, Xuan Zhao, John Paul Fawcett, Xin Xu, Deqi Cai & Jingkai Gu. (2023) Full-profile pharmacokinetics, anticancer activity and toxicity of an extended release trivalent PEGylated irinotecan prodrug. Acta Pharmaceutica Sinica B 13:8, pages 3444-3453.
Crossref
Crossref
Shuo Zhang, Chuanyan Zhang, Jingxian Chen, Feiying Deng, Zezhen Wu, Dan Zhu, Fengwu Chen, Yale Duan, Yue Zhao & Kaijian Hou. (2023) Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial. Frontiers in Pharmacology 14.
Crossref
Crossref
Gubran Khalil Mohammed, Roland Böttger, Andor Krizsan, Daniela Volke, Marina Mötzing, Shyh‐Dar Li, Daniel Knappe & Ralf Hoffmann. (2023) In Vitro Properties and Pharmacokinetics of Temporarily PEGylated Onc72 Prodrugs. Advanced Healthcare Materials 12:11.
Crossref
Crossref
Jannik Paulus, Beate Nachtigall, Peter Meyer & Norbert Sewald. (2023) RGD Peptidomimetic MMAE‐Conjugate Addressing Integrin αVβ3‐Expressing Cells with High Targeting Index**. Chemistry – A European Journal 29:12.
Crossref
Crossref
Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Pragya Prasanna, Manoj Kumar & Madaswamy S. Muthu. 2023. Nanomaterial-Based Drug Delivery Systems. Nanomaterial-Based Drug Delivery Systems
239
268
.
Soyoung Kim, Ilseob Choi, Ik-Hwan Han & Hyunsu Bae. (2022) Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer. International Journal of Molecular Sciences 23:24, pages 15751.
Crossref
Crossref
Rohan Willis, Thomas C. R. McDonnell, Charis Pericleous, Emilio B. Gonzalez, Alvaro Schleh, Zurina Romay-Penabad, Ian P. Giles & Anisur Rahman. (2022) PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome. Frontiers in Immunology 13.
Crossref
Crossref
Jun Hong, Yating Tang, Mengting Zhou, Jing Deng, Hang Hu & Defeng Xu. (2022) Polyethylene glycol-modified mesoporous polydopamine nanoparticles co-loaded with dimethylcurcumin and indocyanine green for combination therapy of castration-resistant prostate cancer. Journal of Drug Delivery Science and Technology 69, pages 103158.
Crossref
Crossref
Christopher N. Subasic, Aditya Ardana, Linda J. Chan, Fei Huang, Judith A. Scoble, Neville J. Butcher, Laurence Meagher, John Chiefari, Lisa M. Kaminskas & Charlotte C. Williams. (2021) Poly(HPMA-co-NIPAM) copolymer as an alternative to polyethylene glycol-based pharmacokinetic modulation of therapeutic proteins. International Journal of Pharmaceutics 608, pages 121075.
Crossref
Crossref
Jianxun Yi, Ang Li, Xuejun Li, Kiho Park, Xinyu Zhou, Frank Yi, Yajuan Xiao, Dosuk Yoon, Tao Tan, Lyle W. Ostrow, Jianjie Ma & Jingsong Zhou. (2021) MG53 Preserves Neuromuscular Junction Integrity and Alleviates ALS Disease Progression. Antioxidants 10:10, pages 1522.
Crossref
Crossref
Caitlin L. Maikawa, Andrea I. d’Aquino, Eric T. Vuong, Bo Su, Lei Zou, Peyton C. Chen, Leslee T. Nguyen, Anton A. A. Autzen, Joseph L. Mann, Matthew J. Webber & Eric A. Appel. (2021)
Affinity-Directed Dynamics of Host–Guest Motifs for Pharmacokinetic Modulation
via
Supramolecular PEGylation
. Biomacromolecules 22:8, pages 3565-3573.
Crossref
Crossref
Faezeh Andisheh, Fatemeh Oroojalian, Neda Shakour, Mohammad Ramezani, Jamal Shamsara, Elham Khodaverdi, Hooriyeh Nassirli, Farzin Hadizadeh & Mona Alibolandi. (2021) Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo. International Journal of Pharmaceutics 605, pages 120822.
Crossref
Crossref
Jose Ramon, Vinicius Gonçalves, Aline Alvarenga, Vivian Saez, Marcio Nele & Tito Alves. (2021)
Integrated Lab-Scale Process Combining Purification and PEGylation of
l
-Asparaginase from
Zymomonas mobilis
. Industrial & Engineering Chemistry Research 60:19, pages 6932-6939.
Crossref
Crossref
Linong Ji, Ying Du, Min Xu, Xiangjun Zhou, Zhaohui Mo, Jianhua Ma, Jiarui Li, Yufeng Li, Jingna Lin, Yanjun Wang, Jing Yang, Weihong Song, Hui Jin, Shuguang Pang, Hui Liu, Ping Li, Jie Liu, Minxiu Yao, Wenhui Li, Xiaohong Jiang, Feixia Shen, Houfa Geng, Haifeng Zhou, Jianmin Ran, Minxiang Lei, Yinghong Du, Shandong Ye, Qingbo Guan, Wenshan Lv, Huiwen Tan, Tao Chen, Jinkui Yang, Guijun Qin, Shiyun Li & Lei Chen. (2021) Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study. Diabetologia 64:5, pages 1066-1078.
Crossref
Crossref
Meilyn Sylvestre, Shixian Lv, Lucy F. Yang, Nicholas Luera, David J. Peeler, Bing-Mae Chen, Steve R. Roffler & Suzie H. Pun. (2021) Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice. Journal of Controlled Release 331, pages 142-153.
Crossref
Crossref
Vanessa Hoguet, Manuel Lasalle, Mathieu Maingot, Geoffroy Dequirez, Rajaa Boulahjar, Florence Leroux, Catherine Piveteau, Adrien Herledan, Alexandre Biela, Julie Dumont, Oscar Chávez-Talavera, Loïc Belloy, Isabelle Duplan, Nathalie Hennuyer, Laura Butruille, Sophie Lestavel, Emmanuel Sevin, Maxime Culot, Fabien Gosselet, Bart Staels, Benoit Deprez, Anne Tailleux & Julie Charton. (2021) Beyond the Rule of 5: Impact of PEGylation with Various Polymer Sizes on Pharmacokinetic Properties, Structure–Properties Relationships of mPEGylated Small Agonists of TGR5 Receptor. Journal of Medicinal Chemistry 64:3, pages 1593-1610.
Crossref
Crossref
Zecong Xiao, Xinyao Zheng, Ying An, Kangning Wang, Junwen Zhang, Huacheng He & Jiang Wu. (2021) Zwitterionic hydrogel for sustained release of growth factors to enhance wound healing. Biomaterials Science 9:3, pages 882-891.
Crossref
Crossref
Oliver Findling & Johann Sellner. (2021) Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?. Drug Discovery Today 26:2, pages 416-428.
Crossref
Crossref
Angelina V. Kazakova, Lyubov G. Rubicheva, Alexander S. Konev & Alexander F. Khlebnikov. (2021) Stereoselective synthesis of PEGylated azoles via 1,3-dipolar cycloaddition. Tetrahedron 77, pages 131774.
Crossref
Crossref
Chao Wang, Mingrui Xiong, Chen Yang, Dong Yang, Jiaojiao Zheng, Yu Fan, Shun Wang, Yongkang Gai, Xiaoli Lan, Hong Chen, Ling Zheng & Kun Huang. (2020) PEGylated and Acylated Elabela Analogues Show Enhanced Receptor Binding, Prolonged Stability, and Remedy of Acute Kidney Injury. Journal of Medicinal Chemistry 63:24, pages 16028-16042.
Crossref
Crossref
A. Sofia Santos & M. Manuel B. Marques. (2020) Pd-Catalyzed Functionalization of Aryl Amines on a Soluble Polymer Support. Synlett 31:20, pages 2027-2034.
Crossref
Crossref
Manjunath Nookala Krishnamurthy, Gaurav Narula, Khushboo Gandhi, Ankita Awase, Ruta Pandit, Sunil Raut, Ritu Singh, Vikram Gota & Shripad Dinanath Banavali. (2020) Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia. JCO Global Oncology:6, pages 1009-1016.
Crossref
Crossref
Jennifer Pfeil, Mario Simonetti, Uta Lauer, Rudolf Volkmer, Bianca von Thülen, Pawel Durek, Ralf Krähmer, Frank Leenders, Alf Hamann & Ute Hoffmann. (2020) Tolerogenic Immunomodulation by PEGylated Antigenic Peptides. Frontiers in Immunology 11.
Crossref
Crossref
Thomas Lindner, Annette Altmann, Susanne Krämer, Christian Kleist, Anastasia Loktev, Clemens Kratochwil, Frederik Giesel, Walter Mier, Frederik Marme, Jürgen Debus & Uwe Haberkorn. (2020)
Design and Development of
99m
Tc-Labeled FAPI Tracers for SPECT Imaging and
188
Re Therapy
. Journal of Nuclear Medicine 61:10, pages 1507-1513.
Crossref
Crossref
Atsushi Mahara, Marina Kitai, Hiroyasu Masunaga, Takaaki Hikima, Yuichi Ohya, Sono Sasaki, Shinichi Sakurai & Tetsuji Yamaoka. (2020) Modification of decellularized vascular xenografts with 8‐arm polyethylene glycol suppresses macrophage infiltration but maintains graft degradability. Journal of Biomedical Materials Research Part A 108:10, pages 2005-2014.
Crossref
Crossref
Mary Filipi & Samantha Jack. (2020) Interferons in the Treatment of Multiple Sclerosis. International Journal of MS Care 22:4, pages 165-172.
Crossref
Crossref
Zhi Zhang, Yuyao Zhang, Shiwen Song, Lei Yin, Dong Sun & Jingkai Gu. (2020) Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals. Journal of Separation Science 43:9-10, pages 1978-1997.
Crossref
Crossref
Sumit Kumar, Devender Singh, Pooja Kumari, Rajender Singh Malik, Poonam, Keykavous Parang & Rakesh Kumar Tiwari. (2020) PEGylation and Cell-Penetrating Peptides: Glimpse into the Past and Prospects in the Future. Current Topics in Medicinal Chemistry 20:5, pages 337-348.
Crossref
Crossref
Jürgen Siekmann & Peter L. Turecek. 2020. Polymer-Protein Conjugates. Polymer-Protein Conjugates
155
174
.
Alonso Ornelas‐González, Stefanie U Reisenauer, Mirna González‐González & Marco Rito‐Palomares. (2019) Characterization and optimization of immunoaffinity aqueous two‐phase systems with PEGylated CD133/2‐biotin antibody in route to stem cell separation. Journal of Chemical Technology & Biotechnology 95:1, pages 123-131.
Crossref
Crossref
Danielle Freches, Natacha Rocks, Harshad P. Patil, Fabienne Perin, Jacques Van Snick, Rita Vanbever & Didier Cataldo. (2019) Preclinical evaluation of topically-administered PEGylated Fab’ lung toxicity. International Journal of Pharmaceutics: X 1, pages 100019.
Crossref
Crossref
Adrian Sanden, Susanna Suhm, Matthias Rüdt & Jürgen Hubbuch. (2019) Fourier-transform infrared spectroscopy as a process analytical technology for near real time in-line estimation of the degree of PEGylation in chromatography. Journal of Chromatography A 1608, pages 460410.
Crossref
Crossref
Ana Castro-Hernández & Norma Aidé Cortez-Lemus. (2019) Thermo/pH Responsive Star and Linear Copolymers Containing a Cholic Acid-Derived Monomer, N-Isopropylacrylamide and Acrylic Acid: Synthesis and Solution Properties. Polymers 11:11, pages 1859.
Crossref
Crossref
Elena A. Morozova, Vitalia V. Kulikova, Natalya V. Anufrieva, Alexey N. Minakov, Alexandr S. Chernov, Georgij B. Telegin, Svetlana V. Revtovich, Vasily S. Koval & Tatyana V. Demidkina. (2019) Methionine γ-lyase in enzyme prodrug therapy: An improvement of pharmacokinetic parameters of the enzyme. International Journal of Biological Macromolecules 140, pages 1277-1283.
Crossref
Crossref
Kamil Rahme & Nazih Dagher. (2019) Chemistry Routes for Copolymer Synthesis Containing PEG for Targeting, Imaging, and Drug Delivery Purposes. Pharmaceutics 11:7, pages 327.
Crossref
Crossref
Lili Wang, Christopher Subasic, Rodney F Minchin & Lisa M Kaminskas. (2019) Drug formulation and nanomedicine approaches to targeting lymphatic cancer metastases. Nanomedicine 14:12, pages 1605-1621.
Crossref
Crossref
Hirofumi OchiaiKenta YoshidaHiroshi ShibutaniAkio KanataniYuji Nishiuchi. (2019) Spontaneously Cleavable Glycosylated Linker Capable of Extended Release of Its Conjugated Peptide. Chemical and Pharmaceutical Bulletin 67:3, pages 236-243.
Crossref
Crossref
M. V. Melnikov, D. S. Kasatkin, A. I. Volkov & A. N. Boyko. (2019) The pegylated form of interferon beta in the treatment of multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:8, pages 136.
Crossref
Crossref
Yara Dadalti Fragoso, Tarso Adoni, Joseph B. Bidin Brooks, Alessandro Finkelsztejn, Paulo Diniz da Gama, Anderson K. Grzesiuk, Vanessa Daccach Marques, Monica Fiuza K. Parolin, Henry K. Sato, Daniel Lima Varela & Claudia Cristina F. Vasconcelos. (2018) Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children. Neurology and Therapy 7:2, pages 207-232.
Crossref
Crossref
Takashi Imada, Koji Moriya, Masahiko Uchiyama, Naoto Inukai, Mitsuhiro Hitotsuyanagi, Akiko Masuda, Takehiro Suzuki, Shotaro Ayukawa, Yo-ichi Tagawa, Naoshi Dohmae, Michinori Kohara, Masayuki Yamamura & Daisuke Kiga. (2018) A Highly Bioactive Lys-Deficient IFN Leads to a Site-Specific Di-PEGylated IFN with Equivalent Bioactivity to That of Unmodified IFN-α2b. ACS Synthetic Biology 7:11, pages 2537-2546.
Crossref
Crossref
Thomas C. R. McDonnell, Rohan Willis, Charis Pericleous, Vera M. Ripoll, Ian P. Giles, David. A. Isenberg, Allan R. Brasier, Emilio B. Gonzalez, Elizabeth Papalardo, Zurina Romay-Penabad, Mohammad Jamaluddin, Yiannis Ioannou & Anisur Rahman. (2018) PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome. Frontiers in Immunology 9.
Crossref
Crossref
Thierry Lambert, Gary Benson, Gerry Dolan, Cedric Hermans, Victor Jiménez-Yuste, Rolf Ljung, Massimo Morfini, Silva Zupančić-Šalek & Elena Santagostino. (2018) Practical aspects of extended half-life products for the treatment of haemophilia. Therapeutic Advances in Hematology 9:9, pages 295-308.
Crossref
Crossref
Sérgio F. Sousa, Joana Peres, Manuel Coelho & Tatiana F. Vieira. (2018) Analyzing PEGylation through Molecular Dynamics Simulations. ChemistrySelect 3:29, pages 8415-8427.
Crossref
Crossref
P. Arndt, N. D. Leistner, S. Neuss, D. Kaltbeitzel, G. A. Brook & J. Grosse. (2018) Artificial urine and FBS supplemented media in cytocompatibility assays for PLGA-PEG-based intravesical devices using the urothelium cell line UROtsa. Journal of Biomedical Materials Research Part B: Applied Biomaterials 106:6, pages 2140-2147.
Crossref
Crossref
Kai N. Sands, Tyler A. Tuck & Thomas G. Back. (2018) Cyclic Seleninate Esters, Spirodioxyselenuranes and Related Compounds: New Classes of Biological Antioxidants That Emulate Glutathione Peroxidase. Chemistry - A European Journal 24:39, pages 9714-9728.
Crossref
Crossref
Hao Tang, Jiajing Zhang, Jin Tang, Yi Shen, Wenxuan Guo, Min Zhou, Ruihua Wang, Ni Jiang, Zhihua Gan & Qingsong Yu. (2018) Tumor Specific and Renal Excretable Star-like Triblock Polymer–Doxorubicin Conjugates for Safe and Efficient Anticancer Therapy. Biomacromolecules 19:7, pages 2849-2862.
Crossref
Crossref
Francesco Roselli, Akila Chandrasekar & Maria C. Morganti-Kossmann. (2018) Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application. Frontiers in Neurology 9.
Crossref
Crossref
Tae Yoon Kim, Hyo-Deok Seo, Joong-jae Lee, Jung Ae Kang, Woo Sik Kim, Hye-Min Kim, Ha-Yeon Song, Ji Min Park, Dong-Eun Lee & Hak-Sung Kim. (2018) A dimeric form of a small-sized protein binder exhibits enhanced anti-tumor activity through prolonged blood circulation. Journal of Controlled Release 279, pages 282-291.
Crossref
Crossref
Ayumu Niida, Yoko Kanematsu-Yamaki, Tomoko Asakawa, Yoshimasa Ishimura, Hisashi Fujita, Kouta Matsumiya, Naoki Nishizawa, Yusuke Adachi, Taisuke Mochida, Kazue Tsuchimori, Mariko Yoneyama-Hirozane, Junichi Sakamoto, Hideki Hirabayashi, Hideo Fukui, Shiro Takekawa & Taiji Asami. (2018) Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives. Bioorganic & Medicinal Chemistry 26:3, pages 566-572.
Crossref
Crossref
H.C. Stephen Chan, Dillon McCarthy, Jianing Li, Krzysztof Palczewski & Shuguang Yuan. (2017) Designing Safer Analgesics via μ-Opioid Receptor Pathways. Trends in Pharmacological Sciences 38:11, pages 1016-1037.
Crossref
Crossref
Pavel Hradílek. (2017) PEGylated interferon beta-1a: a novel interferon in treating multiple sclerosis. Neurologie pro praxi 18:4, pages 253-255.
Crossref
Crossref
Linda J. Chan, Orlagh M. Feeney, Nathania J. Leong, Victoria M. McLeod, Christopher J.H. Porter, Charlotte C. Williams & Lisa M. Kaminskas. (2017) An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration. Biomacromolecules 18:9, pages 2866-2875.
Crossref
Crossref
M-J. Guichard, T. Leal & R. Vanbever. (2017) PEGylation, an approach for improving the pulmonary delivery of biopharmaceuticals. Current Opinion in Colloid & Interface Science 31, pages 43-50.
Crossref
Crossref
Yoko Kanematsu-Yamaki, Naoki Nishizawa, Tomoko Kaisho, Hiroaki Nagai, Taisuke Mochida, Tomoko Asakawa, Hiroshi Inooka, Katsuko Dote, Hisashi Fujita, Kouta Matsumiya, Hideki Hirabayashi, Junichi Sakamoto, Tetsuya Ohtaki, Shiro Takekawa & Taiji Asami. (2017) Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide. Journal of Medicinal Chemistry 60:14, pages 6089-6097.
Crossref
Crossref
Sathish Dyawanapelly, Nishant Kumar Jain, Sindhu KR, Maruthi Prasanna & Akhilesh Vikram Singh. 2017. Handbook of Composites from Renewable Materials. Handbook of Composites from Renewable Materials
483
541
.
Claus Madsen. (2017) The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis. Brain and Behavior 7:6, pages e00696.
Crossref
Crossref
Hiroshi Inooka, Kotaro Sakamoto, Tokuyuki Shinohara, Yasushi Masuda, Michiko Terada, Satoshi Kumano, Kotaro Yokoyama, Jiro Noguchi, Naoki Nishizawa, Hidenori Kamiguchi, Hisashi Fujita, Taiji Asami, Shiro Takekawa & Tetsuya Ohtaki. (2017) A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects. Bioorganic & Medicinal Chemistry 25:8, pages 2307-2312.
Crossref
Crossref
Yevgeniya Le, Wendy M. Toyofuku & Mark D. Scott. (2017) Immunogenicity of murine mPEG-red blood cells and the risk of anti-PEG antibodies in human blood donors. Experimental Hematology 47, pages 36-47.e2.
Crossref
Crossref
Lei Yin, Chong Su, Tianming Ren, Xiangjun Meng, Meiyun Shi, J. Paul Fawcett, Mengliang Zhang, Wei Hu & Jingkai Gu. (2017)
MS
All
strategy for comprehensive quantitative analysis of PEGylated-doxorubicin, PEG and doxorubicin by LC-high resolution q-q-TOF mass spectrometry coupled with all window acquisition of all fragment ion spectra
. The Analyst 142:22, pages 4279-4288.
Crossref
Crossref
Wen-Wei Lin, Yuan-Chin Hsieh, Yi-An Cheng, Kuo-Hsiang Chuang, Chien-Chiao Huang, Chih-Hung Chuang, I-Ju Chen, Kai-Wen Cheng, Yun-Chi Lu, Ta-Chun Cheng, Yeng-Tseng Wang, Steve R. Roffler & Tian-Lu Cheng. (2016) Optimization of an Anti-poly(ethylene glycol) (anti-PEG) Cell-Based Capture System To Quantify PEG and PEGylated Molecules. Analytical Chemistry 88:24, pages 12371-12379.
Crossref
Crossref
Eun Ji Park & Dong Hee Na. (2016) Characterization of the Reversed-Phase Chromatographic Behavior of PEGylated Peptides Based on the Poly(ethylene glycol) Dispersity. Analytical Chemistry 88:22, pages 10848-10853.
Crossref
Crossref
Pavan Bhargava & Scott D. Newsome. (2016) An update on the evidence base for peginterferon β1a in the treatment of relapsing–remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders 9:6, pages 483-490.
Crossref
Crossref
. 2016. Bio-Targets and Drug Delivery Approaches. Bio-Targets and Drug Delivery Approaches
233
252
.
Thananya Jinato, Natthaya Chuaypen, Witthaya Poomipak, Kesmanee Praianantathavorn, Jarika Makkoch, Rattanaporn Kiatbumrung, Kanisa Jampoka, Pisit Tangkijvanich & Sunchai Payungporn. (2016) Original Research: Analysis of hepatic microRNA alterations in response to hepatitis B virus infection and pegylated interferon alpha-2a treatment. Experimental Biology and Medicine 241:16, pages 1803-1810.
Crossref
Crossref
Vladimir N. Podust, Sibu Balan, Bee-Cheng Sim, Michael P. Coyle, Ulrich Ernst, Robert T. Peters & Volker Schellenberger. (2016) Extension of in vivo half-life of biologically active molecules by XTEN protein polymers. Journal of Controlled Release 240, pages 52-66.
Crossref
Crossref
In Taek Song, Mihyun Lee, Hyukjin Lee, Jinah Han, Jae-Hyung Jang, Moon Sue Lee, Gou Young Koh & Haeshin Lee. (2016) PEGylation and HAylation via catechol: α-Amine-specific reaction at N-terminus of peptides and proteins. Acta Biomaterialia 43, pages 50-60.
Crossref
Crossref
Nicole M. R. McNeil, David J. Press, Don M. Mayder, Pablo Garnica, Lisa M. Doyle & Thomas G. Back. (2016) Enhanced Glutathione Peroxidase Activity of Water-Soluble and Polyethylene Glycol-Supported Selenides, Related Spirodioxyselenuranes, and Pincer Selenuranes. The Journal of Organic Chemistry 81:17, pages 7884-7897.
Crossref
Crossref
Christian Reichert, Remo Perozzo & Gerrit Borchard. (2016) Non-covalent modification of granulocyte-colony stimulating factor (G-CSF) by coiled-coil technology. International Journal of Pharmaceutics 511:1, pages 98-103.
Crossref
Crossref
Ola Sternebring, Jesper Kammersgaard Christensen & Inga Bjørnsdottir. (2016) Pharmacokinetics, tissue distribution, excretion, and metabolite profiling of PEGylated rFIX (nonacog beta pegol, N9-GP) in rats. European Journal of Pharmaceutical Sciences 92, pages 163-172.
Crossref
Crossref
Joleen T. White, Scott D. Newsome, Bernd C. Kieseier, Robert A. Bermel, Yue Cui, Ali Seddighzadeh, Serena Hung, Mary Crossman & Meena Subramanyam. (2016) Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial. Therapeutic Advances in Neurological Disorders 9:4, pages 239-249.
Crossref
Crossref
Yumin Oh, Ogyi Park, Magdalena Swierczewska, James P. Hamilton, Jong‐Sung Park, Tae Hyung Kim, Sung‐Mook Lim, Hana Eom, Dong Gyu Jo, Choong‐Eun Lee, Raouf Kechrid, Panagiotis Mastorakos, Clark Zhang, Sei Kwang Hahn, Ok‐Cheol Jeon, Youngro Byun, Kwangmeyung Kim, Justin Hanes, Kang Choon Lee, Martin G. Pomper, Bin Gao & Seulki Lee. (2016) Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells. Hepatology 64:1, pages 209-223.
Crossref
Crossref
Erez M. Bublil, Tomas Majtan, Insun Park, Richard S. Carrillo, Helena Hůlková, Jakub Krijt, Viktor Kožich & Jan P. Kraus. (2016) Enzyme replacement with PEGylated cystathionine β-synthase ameliorates homocystinuria in murine model. Journal of Clinical Investigation 126:6, pages 2372-2384.
Crossref
Crossref
Boris Gorovits, Adrienne Clements-Egan, Mary Birchler, Meina Liang, Heather Myler, Kun Peng, Shobha Purushothama, Manoj Rajadhyaksha, Laura Salazar-Fontana, Crystal Sung & Li Xue. (2016) Pre-existing Antibody: Biotherapeutic Modality-Based Review. The AAPS Journal 18:2, pages 311-320.
Crossref
Crossref
Peter L. Turecek, Mary J. Bossard, Freddy Schoetens & Inge A. Ivens. (2016) PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs. Journal of Pharmaceutical Sciences 105:2, pages 460-475.
Crossref
Crossref
Stuart I. Jenkins, Daniel Weinberg, Arwa F. al-Shakli, Alinda R. Fernandes, Humphrey H.P. Yiu, Neil D. Telling, Paul Roach & Divya M. Chari. (2016) ‘Stealth’ nanoparticles evade neural immune cells but also evade major brain cell populations: Implications for PEG-based neurotherapeutics. Journal of Controlled Release 224, pages 136-145.
Crossref
Crossref
Anna Kwiatkowska, Frédéric Couture, Christine Levesque, Kévin Ly, Sophie Beauchemin, Roxane Desjardins, Witold Neugebauer, Yves L. Dory & Robert Day. (2016) Novel Insights into Structure-Activity Relationships of N-Terminally Modified PACE4 Inhibitors. ChemMedChem 11:3, pages 289-301.
Crossref
Crossref
Yan J Zhang, Linlin Luo & Dharmesh D Desai. (2016) Overview on biotherapeutic proteins: impact on bioanalysis. Bioanalysis 8:1, pages 1-9.
Crossref
Crossref
Hoa Thi Le, Bin Na Hong, Yeong Ro Lee, Ji Hyun Cheon, Tong Ho Kang & Tae Woo Kim. (2016) Regulatory effect of hydroquinone–tetraethylene glycol conjugates on zebrafish pigmentation. Bioorganic & Medicinal Chemistry Letters 26:2, pages 699-705.
Crossref
Crossref
B. Paul Morgan & Claire L. Harris. (2015) Complement, a target for therapy in inflammatory and degenerative diseases. Nature Reviews Drug Discovery 14:12, pages 857-877.
Crossref
Crossref
Yvonne J. Rosenberg, Robert J. Adams, Segundo Hernandez-Abanto, Xiaoming Jiang, Wei Sun, Lingjun Mao & K. David Lee. (2015) Pharmacokinetics and immunogenicity of a recombinant human butyrylcholinesterase bioscavenger in macaques following intravenous and pulmonary delivery. Chemico-Biological Interactions 242, pages 219-226.
Crossref
Crossref
Inge A. Ivens, William Achanzar, Andreas Baumann, Annamaria Br?ndli-Baiocco, Joy Cavagnaro, Maggie Dempster, B. Olympe Depelchin, Armando R. Irizarry Rovira, Laura Dill-Morton, Joan H. Lane, Birgit M. Reipert, Theodora Salcedo, Becky Schweighardt, Laurie S. Tsuruda, Peter L. Turecek & Jennifer Sims. (2015) PEGylated Biopharmaceuticals. Toxicologic Pathology 43:7, pages 959-983.
Crossref
Crossref
. (2015) Multiple Sklerose. Auf dem Weg zur individualisierten Therapie. psychopraxis. neuropraxis 18:5, pages 192-193.
Crossref
Crossref
Bahman Khameneh, Mahmoud Reza Jaafari, Mohammad Hassanzadeh-Khayyat, AbdolReza Varasteh, JamshidKhan Chamani, Mehrdad Iranshahi, Hamid Mohammadpanah, Khalil Abnous & Mohammad Reza Saberi. (2015) Preparation, characterization and molecular modeling of PEGylated human growth hormone with agonist activity. International Journal of Biological Macromolecules 80, pages 400-409.
Crossref
Crossref
Murli Krishna, Holly Palme, Jia Duo, Zheng Lin, Martin Corbett, Robert Dodge, Steven Piccoli, Heather Myler, Renuka Pillutla & Binodh Desilva. (2015) Development and characterization of antibody reagents to assess anti-PEG IgG antibodies in clinical samples. Bioanalysis 7:15, pages 1869-1883.
Crossref
Crossref
William R. Strohl. (2015) Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters. BioDrugs 29:4, pages 215-239.
Crossref
Crossref
Alex Bunker. 2015. Computational Pharmaceutics. Computational Pharmaceutics
217
233
.
Hsin-Yi Tung, Yu-Cheng Su, Bing-Mae Chen, Pierre-Alain Burnouf, Wei-Chiao Huang, Kuo-Hsiang Chuang, Yu-Ting Yan, Tian-Lu Cheng & Steve R. Roffler. (2015) Selective Delivery of PEGylated Compounds to Tumor Cells by Anti-PEG Hybrid Antibodies. Molecular Cancer Therapeutics 14:6, pages 1317-1326.
Crossref
Crossref
Chris Barnes. (2015) Recent Advances in Haemophilia Management. Current Pediatrics Reports 3:2, pages 154-159.
Crossref
Crossref
V.I. Leussink, C. Warnke, B. Tackenberg, H. Wiendl & B.C. Kieseier. (2015) Pegyliertes Interferon-beta 1aPegylated interferon beta 1a. Der Nervenarzt 86:4, pages 483-490.
Crossref
Crossref
Eun Ji Park, Myung Sun Kim, Hye Suk Lee, Kang Choon Lee & Dong Hee Na. (2015) Differences in electrophoretic behavior between linear and branched PEG-conjugated proteins. ELECTROPHORESIS 36:6, pages 918-923.
Crossref
Crossref
Xiwen Li, Hua Li, Yongye Zhao, Xiaoying Tang, Sufang Ma, Bing Gong & Minfeng Li. (2015) Facile synthesis of well-defined hydrophilic polyesters as degradable poly(ethylene glycol)-like biomaterials. Polymer Chemistry 6:36, pages 6452-6456.
Crossref
Crossref
Myung Sun Kim, Eun Ji Park & Dong Hee Na. (2015) Synthesis and characterization of monodisperse poly(ethylene glycol)-conjugated collagen pentapeptides with collagen biosynthesis-stimulating activity. Bioorganic & Medicinal Chemistry Letters 25:1, pages 38-42.
Crossref
Crossref
Sara Movassaghian & Vladimir P. Torchilin. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
433
462
.
Bethanne Murphy, Maria C.M. Parrula, Christopher J. Perigard & Jinze Li. (2014) Artifactual prolongation of activated partial thromboplastin time with PEGylated compounds in silica-based assays. Blood Coagulation & Fibrinolysis 25:8, pages 876-882.
Crossref
Crossref
P. M. Mannucci. (2014) Half-life extension technologies for haemostatic agents. Thrombosis and Haemostasis 113:1, pages 165-176.
Crossref
Crossref
Claire Ginn, Hanieh Khalili, Rebecca Lever & Steve Brocchini. (2014) PEGylation and its impact on the design of new protein-based medicines. Future Medicinal Chemistry 6:16, pages 1829-1846.
Crossref
Crossref
Atul Kolate, Dipesh Baradia, Sushilkumar Patil, Imran Vhora, Girish Kore & Ambikanandan Misra. (2014) PEG — A versatile conjugating ligand for drugs and drug delivery systems. Journal of Controlled Release 192, pages 67-81.
Crossref
Crossref
Alicia J. Sawdon & Ching-An Peng. (2014) Polymeric micelles for acyclovir drug delivery. Colloids and Surfaces B: Biointerfaces 122, pages 738-745.
Crossref
Crossref
Jianwei Liu, Zhu Wang, Jintian He, Gaizhen Wang, Rongbo Zhang & Baohua Zhao. (2014) Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase. Acta Biochimica et Biophysica Sinica 46:9, pages 782-791.
Crossref
Crossref
Patrick A. Baeuerle & Jerry A. Murry. (2014) Human Therapies as a Successful Liaison between Chemistry and Biology. Chemistry & Biology 21:9, pages 1046-1054.
Crossref
Crossref
Lindsey Crawford & David Putnam. (2014) Synthesis and Characterization of Macromolecular Rhodamine Tethers and Their Interactions with P-Glycoprotein. Bioconjugate Chemistry 25:8, pages 1462-1469.
Crossref
Crossref
Jiachang Gong, Xiaomei Gu, William E. Achanzar, Kristina D. Chadwick, Jinping Gan, Barry J. Brock, Narendra S. Kishnani, W. Griff Humphreys & Ramaswamy A. Iyer. (2014) Quantitative Analysis of Polyethylene Glycol (PEG) and PEGylated Proteins in Animal Tissues by LC-MS/MS Coupled with In-Source CID. Analytical Chemistry 86:15, pages 7642-7649.
Crossref
Crossref
Lin Dai, Luying Wang, Lihong Deng, Jing Liu, Jiandu Lei, Dan Li & Jing He. (2014) Novel Multiarm Polyethylene glycol-Dihydroartemisinin Conjugates Enhancing Therapeutic Efficacy in Non-Small-Cell Lung Cancer. Scientific Reports 4:1.
Crossref
Crossref
J-M. Gu, P. Ramsey, V. Evans, L. Tang, H. Apeler, L. Leong, J. E. Murphy, V. Laux & T. Myles. (2014) Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A. Haemophilia 20:4, pages 593-600.
Crossref
Crossref
Hans-Peter Hartung. (2014) Interferon beta-1a for multiple sclerosis: old drug, new clothes. The Lancet Neurology 13:7, pages 638-639.
Crossref
Crossref
Hidetoshi Noda, Gábor Erős & Jeffrey W. Bode. (2014) Rapid Ligations with Equimolar Reactants in Water with the Potassium Acyltrifluoroborate (KAT) Amide Formation. Journal of the American Chemical Society 136:15, pages 5611-5614.
Crossref
Crossref
Alleyn T. Plowright, Ola Engkvist, Adrian Gill, Laurent Knerr & Qing‐Dong Wang. (2014) Heart Regeneration: Opportunities and Challenges for Drug Discovery with Novel Chemical and Therapeutic Methods or Agents. Angewandte Chemie International Edition 53:16, pages 4056-4075.
Crossref
Crossref
Alleyn T. Plowright, Ola Engkvist, Adrian Gill, Laurent Knerr & Qing‐Dong Wang. (2014) Herzregeneration: Chancen und Aufgaben für die Wirkstoff‐Forschung mit neuartigen chemischen und therapeutischen Methoden oder Agentien. Angewandte Chemie 126:16, pages 4138-4159.
Crossref
Crossref
Gerardo Caruso, Daniele Marino & Maria Caffo. (2014) Nanoparticles and CNS Delivery of Therapeutic Agents in the Treatment of Primary Brain Tumors. Journal of Analytical Oncology 3:2.
Crossref
Crossref
Swapnil V. Bhujbal, Paul de Vos & Simone P. Niclou. (2014) Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors. Advanced Drug Delivery Reviews 67-68, pages 142-153.
Crossref
Crossref
Antonio M. RisitanoDaniel RicklinYijun HuangEdimara S. ReisHui ChenPatrizia RicciZhuoer LinCaterina PascarielloMaddalena RaiaMichela SicaLuigi Del VecchioFabrizio PaneFlorea Lupu, Rosario NotaroRanillo R. G. Resuello, Robert A. DeAngelisJohn D. Lambris. (2014) Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria. Blood 123:13, pages 2094-2101.
Crossref
Crossref
Akvile Haeckel, Franziska Appler, Lena Figge, Harald Kratz, Mathias Lukas, Roger Michel, Jörg Schnorr, Marietta Zille, Bernd Hamm & Eyk Schellenberger. (2014) XTEN-Annexin A5: XTEN Allows Complete Expression of Long-Circulating Protein-Based Imaging Probes as Recombinant Alternative to PEGylation. Journal of Nuclear Medicine 55:3, pages 508-514.
Crossref
Crossref
T. McDonnell, Y. Ioannou & A. Rahman. (2013) PEGylated drugs in rheumatology--why develop them and do they work?. Rheumatology 53:3, pages 391-396.
Crossref
Crossref
Marya Ahmed & Ravin Narain. 2014. Chemistry of Bioconjugates. Chemistry of Bioconjugates
431
443
.
Shen Hong, Han Haibing, Hu Jialiang, Zhang Xiaojuan, Wang Jingjing, Wang Wenjing, Nie Caihui & Xu Hanmei. (2014) PEGylated HM-3 presents anti-rheumatic bioactivity by inhibiting angiogenesis and inflammation. J. Mater. Chem. B 2:7, pages 800-813.
Crossref
Crossref
Anne Marie V. Schou-Pedersen, Jesper ?stergaard, Mats Johansson, Stephane Dubant, Rune B. Frederiksen & Steen Honor? Hansen. (2014) Evaluation of supercritical fluid chromatography for testing of PEG adducts in pharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis 88, pages 256-261.
Crossref
Crossref
Dana L. Kyluik-Price, Li Li & Mark D. Scott. (2014) Comparative efficacy of blood cell immunocamouflage by membrane grafting of methoxypoly(ethylene glycol) and polyethyloxazoline. Biomaterials 35:1, pages 412-422.
Crossref
Crossref
Chengzao Sun, James L. Trevaskis, Carolyn M. Jodka, Swetha Neravetla, Pete Griffin, Kui Xu, Yan Wang, David G. Parkes, Bruce Forood & Soumitra S. Ghosh. (2013) Bifunctional PEGylated Exenatide-Amylinomimetic Hybrids to Treat Metabolic Disorders: An Example of Long-Acting Dual Hormonal Therapeutics. Journal of Medicinal Chemistry 56:22, pages 9328-9341.
Crossref
Crossref
Monika Farys, Claire L. Ginn, George O. Badescu, Karolina Peciak, Estera M. Pawlisz, Hanieh Khalili & Steve J. Brocchini. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
52
.
Hanieh Khalili, Antony Godwin, Ji-won Choi, Rebecca Lever, Peng T. Khaw & Steve Brocchini. (2013) Fab-PEG-Fab as a Potential Antibody Mimetic. Bioconjugate Chemistry 24:11, pages 1870-1882.
Crossref
Crossref
V. N. Podust, B.-C. Sim, D. Kothari, L. Henthorn, C. Gu, C.-w. Wang, B. McLaughlin & V. Schellenberger. (2013) Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer. Protein Engineering Design and Selection 26:11, pages 743-753.
Crossref
Crossref
Qingyuan Liu, Michael R. De Felippis & Lihua Huang. (2013) Method for Characterization of PEGylated Bioproducts in Biological Matrixes. Analytical Chemistry 85:20, pages 9630-9637.
Crossref
Crossref
Friederike Inga Nollmann, Tina Goldbach, Nicole Berthold & Ralf Hoffmann. (2013) Controlled Systemic Release of Therapeutic Peptides from PEGylated Prodrugs by Serum Proteases. Angewandte Chemie International Edition 52:29, pages 7597-7599.
Crossref
Crossref
Friederike Inga Nollmann, Tina Goldbach, Nicole Berthold & Ralf Hoffmann. (2013) Kontrollierte systemische Freisetzung therapeutischer Peptide aus PEGylierten Prodrugs durch Serumproteasen. Angewandte Chemie 125:29, pages 7747-7750.
Crossref
Crossref
Alicia Sawdon & Ching-An Peng. (2013) Engineering antiphagocytic biomimetic drug carriers. Therapeutic Delivery 4:7, pages 825-839.
Crossref
Crossref
GuiLan Sun, Xiao Lin, Lan Shen, Fei Wu, DeSheng Xu, KeFeng Ruan & Yi Feng. (2013) Mono-PEGylated radix ophiopogonis polysaccharide for the treatment of myocardial ischemia. European Journal of Pharmaceutical Sciences 49:4, pages 629-636.
Crossref
Crossref
Huub Schellekens, Wim E. Hennink & Vera Brinks. (2013) The Immunogenicity of Polyethylene Glycol: Facts and Fiction. Pharmaceutical Research 30:7, pages 1729-1734.
Crossref
Crossref
Tae Hyung Kim, Magdalena Swierczewska, Yumin Oh, AeRyon Kim, Dong Gyu Jo, Jae Hyung Park, Youngro Byun, Scheherazade Sadegh‐Nasseri, Martin G. Pomper, Kang Choon Lee & Seulki Lee. (2013) Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins In Vivo. Angewandte Chemie International Edition 52:27, pages 6880-6884.
Crossref
Crossref
Tae Hyung Kim, Magdalena Swierczewska, Yumin Oh, AeRyon Kim, Dong Gyu Jo, Jae Hyung Park, Youngro Byun, Scheherazade Sadegh‐Nasseri, Martin G. Pomper, Kang Choon Lee & Seulki Lee. (2013) Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins In Vivo. Angewandte Chemie 125:27, pages 7018-7022.
Crossref
Crossref
Pradeep K. Dhal, Steven C. Polomoscanik, Diego A. Gianolio, Patrick G. Starremans, Michelle Busch, Kim Alving, Bo Chen & Robert J. Miller. (2013)
Well-Defined Aminooxy Terminated
N
-(2-Hydroxypropyl) Methacrylamide Macromers for Site Specific Bioconjugation of Glycoproteins
. Bioconjugate Chemistry 24:6, pages 865-877.
Crossref
Crossref
Lisa M. Kaminskas, David B. Ascher, Victoria M. McLeod, Marco J. Herold, Caroline P. Le, Erica K. Sloan & Christopher J.H. Porter. (2013) PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases. Journal of Controlled Release 168:2, pages 200-208.
Crossref
Crossref
Wenjun Li, Peng Zhan, Erik De Clercq, Hongxiang Lou & Xinyong Liu. (2013) Current drug research on PEGylation with small molecular agents. Progress in Polymer Science 38:3-4, pages 421-444.
Crossref
Crossref
Annabelle Patricia Herrington-Symes, Monika Farys, Hanieh Khalili & Steve Brocchini. (2013) Antibody fragments: Prolonging circulation half-life special issue-antibody research. Advances in Bioscience and Biotechnology 04:05, pages 689-698.
Crossref
Crossref
I. A. Ivens, A. Baumann, T. A. McDonald, T. J. Humphries, L. A. Michaels & P. Mathew. (2013) PEGylated therapeutic proteins for haemophilia treatment: a review for haemophilia caregivers. Haemophilia 19:1, pages 11-20.
Crossref
Crossref
Roger H. Pak & Rory F. Finn. 2013. Sterile Product Development. Sterile Product Development
61
97
.
Tae Hyung Kim, Hai Hua Jiang, Sung Mook Lim, Yu Seok Youn, Ki Young Choi, Seulki Lee, Xiaoyuan Chen, Youngro Byun & Kang Choon Lee. (2012) Site-Specific PEGylated Exendin-4 Modified with a High Molecular Weight Trimeric PEG Reduces Steric Hindrance and Increases Type 2 Antidiabetic Therapeutic Effects. Bioconjugate Chemistry 23:11, pages 2214-2220.
Crossref
Crossref
Min Li. 2012. Organic Chemistry of Drug Degradation. Organic Chemistry of Drug Degradation
262
277
.
Saibal Bandyopadhyay, Xin Xia, Andrei Maiseiyeu, Georgeta Mihai, Sanjay Rajagopalan & Dennis Bong. (2012) Z-Group Ketone Chain Transfer Agents for RAFT Polymer Nanoparticle Modification via Hydrazone Conjugation. Macromolecules 45:17, pages 6766-6773.
Crossref
Crossref
I. A. Puchkov, N. V. Kononova, A. I. Bobruskin, D. I. Bairamashvili, V. A. Mart’yanov & A. M. Shuster. (2012) Recombinant granulocyte colony-stimulating factor (filgrastim): Optimization of conjugation conditions with polyethylene glycol. Russian Journal of Bioorganic Chemistry 38:5, pages 479-487.
Crossref
Crossref
Tae Hyung Kim, Young Gi Jo, Hai Hua Jiang, Sung Mook Lim, Yu Seok Youn, Seulki Lee, Xiaoyuan Chen, Youngro Byun & Kang Choon Lee. (2012) PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting. Journal of Controlled Release 162:2, pages 422-428.
Crossref
Crossref
GuiLan Sun, Xiao Lin, YanLong Hong, Yi Feng, KeFeng Ruan & DeSheng Xu. (2012) PEGylation for drug delivery to ischemic myocardium: Pharmacokinetics and cardiac distribution of poly(ethylene glycol)s in mice with normal and ischemic myocardium. European Journal of Pharmaceutical Sciences 46:5, pages 545-552.
Crossref
Crossref
Chun Zhang, Kai Fan, Hua Luo, Xuefeng Ma, Riyong Liu, Li Yang, Chunlan Hu, Zhenmin Chen, Zhiqiang Min & Dongzhi Wei. (2012) Characterization, efficacy, pharmacokinetics, and biodistribution of 5 kDa mPEG modified tetrameric canine uricase variant. International Journal of Pharmaceutics 430:1-2, pages 307-317.
Crossref
Crossref
Dong-Hwan Kim, Bin Na Hong, Hoa Thi Le, Ha Na Hong, Choon Woo Lim, Keun Ha Park, Tae Woo Kim & Tong Ho Kang. (2012) Small molecular weight PEGylation of diosgenin in an in vivo animal study for diabetic auditory impairment treatment. Bioorganic & Medicinal Chemistry Letters 22:14, pages 4609-4612.
Crossref
Crossref
Shashwat S. Banerjee, Naval Aher, Rajesh Patil & Jayant Khandare. (2012) Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications. Journal of Drug Delivery 2012, pages 1-17.
Crossref
Crossref
Victoria L. Elliott, George T. Edge, Marie M. Phelan, Lu-Yun Lian, Rob Webster, Rory F. Finn, B. Kevin Park & Neil R. Kitteringham. (2012)
Evidence for Metabolic Cleavage of a PEGylated Protein
in Vivo
Using Multiple Analytical Methodologies
. Molecular Pharmaceutics 9:5, pages 1291-1301.
Crossref
Crossref
Joan Malmstrøm. (2012) Characterization of 40 kDa poly(ethylene glycol) polymers by proton transfer reaction QTOF mass spectrometry and 1H-NMR spectroscopy. Analytical and Bioanalytical Chemistry 403:4, pages 1167-1177.
Crossref
Crossref
Simona Jevševar & Menči Kunstelj. 2012. Therapeutic Proteins. Therapeutic Proteins
39
61
.
Bernd C. Kieseier & Peter A. Calabresi. (2012) PEGylation of Interferon-β-1a. CNS Drugs 26:3, pages 205-214.
Crossref
Crossref
Yuehua Cong, Estera Pawlisz, Penny Bryant, Sibu Balan, Emmanuelle Laurine, Rita Tommasi, Ruchi Singh, Sitara Dubey, Karolina Peciak, Matthew Bird, Amrita Sivasankar, Julia Swierkosz, Maurizio Muroni, Sibylle Heidelberger, Monika Farys, Farzad Khayrzad, Jeff Edwards, George Badescu, Ian Hodgson, Charles Heise, Satyanarayana Somavarapu, John Liddell, Keith Powell, Mire Zloh, Ji-won Choi, Antony Godwin & Steve Brocchini. (2012) Site-Specific PEGylation at Histidine Tags. Bioconjugate Chemistry 23:2, pages 248-263.
Crossref
Crossref
Krishna Hari Bhandari, Madhuri Newa, Jillian Chapman & Michael R. Doschak. (2012) Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats. Journal of Controlled Release 158:1, pages 44-52.
Crossref
Crossref
. 2012. Therapeutic Antibody Engineering. Therapeutic Antibody Engineering
265
595
.
Marianela González, Ricardo J.A. Grau & Santiago E. Vaillard. (2012) New method for the synthesis and purification of branched mPEG2lys. Reactive and Functional Polymers 72:1, pages 107-113.
Crossref
Crossref
. 2012. Therapeutic Antibody Engineering. Therapeutic Antibody Engineering
459
595
.
Francesco Pennacchio, Barbara Giordana & Rosa Rao. 2012. Parasitoid Viruses. Parasitoid Viruses
269
283
.
Roberta Noberini, Sayantan Mitra, Ombretta Salvucci, Fatima Valencia, Srinivas Duggineni, Natalie Prigozhina, Ke Wei, Giovanna Tosato, Ziwei Huang & Elena B. Pasquale. (2011) PEGylation Potentiates the Effectiveness of an Antagonistic Peptide That Targets the EphB4 Receptor with Nanomolar Affinity. PLoS ONE 6:12, pages e28611.
Crossref
Crossref
Jae Hwa Ahn, Eun Ji Park, Hye Suk Lee, Kang Choon Lee & Dong Hee Na. (2011) Reversible Blocking of Amino Groups of Octreotide for the Inhibition of Formation of Acylated Peptide Impurities in Poly(Lactide-co-Glycolide) Delivery Systems. AAPS PharmSciTech 12:4, pages 1220-1226.
Crossref
Crossref
Gaia Cermenati, Irma Terracciano, Ilaria Castelli, Barbara Giordana, Rosa Rao, Francesco Pennacchio & Morena Casartelli. (2011) The CPP Tat enhances eGFP cell internalization and transepithelial transport by the larval midgut of Bombyx mori (Lepidoptera, Bombycidae). Journal of Insect Physiology 57:12, pages 1689-1697.
Crossref
Crossref
Sibylle Jablonka, Bettina Holtmann, Michael Sendtner & Friedrich Metzger. (2011) Therapeutic effects of PEGylated insulin-like growth factor I in the pmn mouse model of motoneuron disease. Experimental Neurology 232:2, pages 261-269.
Crossref
Crossref
Xiao Lin, Zhuo-Jun Wang, Shuo Wang, Lan Shen, Yi Feng, Ke-Feng Ruan & De-Sheng Xu. (2011) Comparison of tissue distribution of a PEGylated Radix Ophiopogonis polysaccharide in mice with normal and ischemic myocardium. European Journal of Pharmaceutics and Biopharmaceutics 79:3, pages 621-626.
Crossref
Crossref
Bing Zhang, Edward W. Towers, Leszek Poppe & Steven L. Cockrill. (2011) Analytical characterization of a novel degradation product in a PEGylated recombinant protein. Journal of Pharmaceutical Sciences 100:11, pages 4607-4616.
Crossref
Crossref
Hong Zhao, Lee M. Greenberger & Ivan D. Horak. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology
627
665
.
Ruchi Bansal, Eduard Post, Johannes H. Proost, Alie de Jager-Krikken, Klaas Poelstra & Jai Prakash. (2011) PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis. Journal of Controlled Release 154:3, pages 233-240.
Crossref
Crossref
Dong-Hee Na. (2011) Development of Protein Drugs by PEGylation Technology. KSBB Journal 26:4, pages 293-299.
Crossref
Crossref
Tae Hyung Kim, Yu Seok Youn, Hai Hua Jiang, Seulki Lee, Xiaoyuan Chen & Kang Choon Lee. (2011) PEGylated TNF-Related Apoptosis-Inducing Ligand (TRAIL) Analogues: Pharmacokinetics and Antitumor Effects. Bioconjugate Chemistry 22:8, pages 1631-1637.
Crossref
Crossref
Teerapol Srichana & Tan Suwandecha. 2011. Biodegradable Polymers in Clinical Use and Clinical Development. Biodegradable Polymers in Clinical Use and Clinical Development
451
493
.
Utpal Bora, Dileep Kumar Kannoujia, Saroj Kumar, Pragya Sharma & Pradip Nahar. (2011) Photochemical activation of polyethylene glycol and its application in PEGylation of protein. Process Biochemistry 46:6, pages 1380-1383.
Crossref
Crossref
Sung Mook Lim, Tae Hyung Kim, Hai Hua Jiang, Chan Woong Park, Seulki Lee, Xiaoyuan Chen & Kang Choon Lee. (2011) Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles. Biomaterials 32:13, pages 3538-3546.
Crossref
Crossref
Tae Hyung Kim, Hai Hua Jiang, Seulki Lee, Yu Seok Youn, Chan Woong Park, Youngro Byun, Xiaoyuan Chen & Kang Choon Lee. (2011) Mono-PEGylated Dimeric Exendin-4 as High Receptor Binding and Long-Acting Conjugates for Type 2 Anti-Diabetes Therapeutics. Bioconjugate Chemistry 22:4, pages 625-632.
Crossref
Crossref
Zhendong Liu, Yinling Ren, Li Pan & Han-Mei Xu. (2011) In Vivo Anti-Tumor Activity of Polypeptide HM-3 Modified by Different Polyethylene Glycols (PEG). International Journal of Molecular Sciences 12:4, pages 2650-2663.
Crossref
Crossref
Celesta Fong, Asoka Weerawardena, Sharon M. Sagnella, Xavier Mulet, Irena Krodkiewska, Josephine Chong & Calum J. Drummond. (2011) Monodisperse Nonionic Isoprenoid-Type Hexahydrofarnesyl Ethylene Oxide Surfactants: High Throughput Lyotropic Liquid Crystalline Phase Determination. Langmuir 27:6, pages 2317-2326.
Crossref
Crossref
James M. Wooten. (2011) Adverse Drug Effects and Pegylation. Southern Medical Journal 104:2, pages 83-84.
Crossref
Crossref
Charlotte Pinholt, Jens Thostrup Bukrinsky, Susanne Hostrup, Sven Frokjaer, Willem Norde & Lene Jorgensen. (2011) Influence of PEGylation with linear and branched PEG chains on the adsorption of glucagon to hydrophobic surfaces. European Journal of Pharmaceutics and Biopharmaceutics 77:1, pages 139-147.
Crossref
Crossref
Alfred J. Harvey, Scott A. Kaestner, Diane E. Sutter, Noel G. Harvey, John A. Mikszta & Ronald J. Pettis. (2010) Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs. Pharmaceutical Research 28:1, pages 107-116.
Crossref
Crossref
Stephen Tilley, Jon Volmer & Maryse Picher. 2011. Purinergic Regulation of Respiratory Diseases. Purinergic Regulation of Respiratory Diseases
235
276
.
Fabio Pastorino, Monica Loi, Puja Sapra, Pamela Becherini, Michele Cilli, Laura Emionite, Domenico Ribatti, Lee M. Greenberger, Ivan D. Horak & Mirco Ponzoni. (2010) Tumor Regression and Curability of Preclinical Neuroblastoma Models by PEGylated SN38 (EZN-2208), a Novel Topoisomerase I Inhibitor. Clinical Cancer Research 16:19, pages 4809-4821.
Crossref
Crossref
Vincent F. M. Segers & Richard T. Lee. (2010) Protein Therapeutics for Cardiac Regeneration after Myocardial Infarction. Journal of Cardiovascular Translational Research 3:5, pages 469-477.
Crossref
Crossref
Yeoun Jin Kim & Michael L. Doyle. (2010) Structural Mass Spectrometry in Protein Therapeutics Discovery. Analytical Chemistry 82:17, pages 7083-7089.
Crossref
Crossref
Yvonne J. Rosenberg, Ashima Saxena, Wei Sun, Xiaoming Jiang, Nageswararao Chilukuri, Chunjuan Luo, Bhupendra P. Doctor & Keunmyoung D. Lee. (2010) Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model. Chemico-Biological Interactions 187:1-3, pages 279-286.
Crossref
Crossref
Yang Xu, John T. Mehl, Ray Bakhtiar & Eric J. Woolf. (2010) Immunoaffinity Purification Using Anti-PEG Antibody Followed by Two-Dimensional Liquid Chromatography/Tandem Mass Spectrometry for the Quantification of a PEGylated Therapeutic Peptide in Human Plasma. Analytical Chemistry 82:16, pages 6877-6886.
Crossref
Crossref
Mehran Salehpour, Jonas Ekblom, Vladimir Sabetsky, Karl Håkansson & Göran Possnert. (2010) Accelerator mass spectrometry offers new opportunities for microdosing of peptide and protein pharmaceuticals. Rapid Communications in Mass Spectrometry 24:10, pages 1481-1489.
Crossref
Crossref
Displaying 200 of 205 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list